Continuous difference-in-differences with double/debiased machine learning
summary
The gist
Continuous difference-in-differences with double/debiased machine learning extends difference-in-differences to settings with continuous treatments by proposing estimators under a conditional…
In short
The paper extends difference-in-differences to settings with continuous treatments by proposing estimators under a conditional parallel trends assumption. It uses double/debiased machine learning to estimate the average treatment effect at any given treatment intensity, establishing their asymptotic normality and providing methods for inference.
Key concepts
- Difference-in-Differences (DiD)
- A statistical method used to estimate the causal effect of a policy or intervention by comparing changes in outcomes between a group that received the treatment and a control group that did not. It relies on the assumption that, without the treatment, both groups would have followed similar trends over time.
- Continuous Treatment Intensity (d)
- This refers to situations where the treatment is not binary (yes/no) but rather a continuous variable, such as a percentage of patients receiving a new medical procedure. The goal is to estimate how the outcome changes for every possible level of this continuous treatment intensity.
- Double/Debiased Machine Learning (DML)
- A powerful machine learning framework used to estimate causal parameters in high-dimensional settings. It helps reduce bias by using a combination of nuisance parameter estimation and machine learning techniques, ensuring that the final causal estimate is robust and asymptotically normal.
Terminology used across episodes
This episode discusses
- Continuous difference-in-differences with double/debiased machine learning · Paper Radio
- Data-adaptive smoothing for optimal-rate estimation of possibly non-regular parameters
- Difference-in-Differences with Multiple Time Periods
- Difference-in-Differences Estimators for Treatments Continuously Distributed at Every Period · Paper Radio
- Difference-in-Differences with Time-varying Continuous Treatments using Double/Debiased Machine Learning
- Difference-in-Differences with Compositional Changes
- Efficient Difference-in-Differences Estimation with High-Dimensional Common Trend Confounding
The paper
Continuous difference-in-differences with double/debiased machine learning · Read on arXiv
Lucas Zheng Zhang
University of California, Los Angeles · Bates White Economic Consulting
DOI: 10.1093/ectj/utaf024
Transcript
Introduction to the show: ident: Economics. The day in economics: theory, mechanisms and the evidence beneath them.
Ruth: I'm Ruth.
Warren: And I'm Warren, here with Iris.
Ruth: We're looking at the paper: "Continuous difference-in-differences with double/debiased machine learning".
Warren: Here's the gist of the paper. Continuous difference-in-differences with double/debiased machine learning extends difference-in-differences to settings with continuous treatments by proposing estimators under a conditional parallel trends assumption and establishing their asymptotic normality using the double/debiased machine learning framework <ref:2408.10509#pg2>.
Ruth: Identification Framework The paper extends difference-in-differences to settings with continuous treatments by proposing estimators under a conditional parallel trends assumption and establishing their asymptotic normality using the double/debiased machine learning framework <ref:2408.10509#pg4>.
Warren: The identification results are based on a conditional parallel trends assumption, allowing researchers to account for covariates non-parametrically <ref:2408.10509#pg7>.
Ruth: The target parameter is the average treatment effect on the treated (ATT for short) at any given continuous treatment intensity d, defined as AT T(d):= E
Yt(d) − Yt(0)D = d: <ref:2408.10509#pg3>.
Paper summary: Ruth: So to recap the main thrust of this paper, they are extending difference-in-differences to settings with continuous treatments by proposing estimators under a conditional parallel trends assumption and establishing their asymptotic normality using the double/debiased machine learning framework <ref:2408.10509#pg4>.
Warren: The core claim is that they can now identify the average treatment effect on the treated at any level of treatment intensity, AT T(d), even when you have continuous treatments <ref:2408.10509#pg3>.
Iris: They address the problem by first estimating infinite-dimensional nuisance parameters, specifically the conditional density of that continuous treatment, which they know can cause substantial bias <ref:2408.10509#pg4>.
Ruth: To counter that, they propose estimators for causal parameters using the double/debiased machine learning framework and prove their asymptotic normality <ref:2408.10509#pg4>. They introduce an approximate causal parameter AT Th using a kernel function to get around the direct application of those ML methods <ref:2408.10509#pg4>.
Warren: The motivation is clear: continuous treatments are common, and you can investigate how outcomes vary across different treatment intensities within the treated group <ref:2408.10509#pg2>.
Iris: And they use a conditional parallel trends assumption to make the identification robust, which lets them condition on covariates that influence outcome dynamics <ref:2408.10509#pg3>.
Ruth: The implication is that instead of just looking at an aggregate effect, you can look at how the effect changes as the treatment dose increases <ref:2408.10509#pg2>.
Warren: It’s a way to investigate those varying levels of exposure without having to rely on simpler models that might miss important nuances <ref:2408.10509#pg8>.
Conclusion: Ruth: So looking at "Continuous difference-in-differences with double/debiased machine learning," the authors are basically giving us a way to handle continuous treatment variables in difference-in-differences settings <ref:2408.10509#pg1>.
Warren: They’ve shown that by using double/debiased machine learning, you can get estimators for the causal parameters and prove they have asymptotic normality <ref:2408.10509#pg4>.
Iris: The real implication is that this gives researchers new tools for examining the impacts of continuous treatment variables in empirical research <ref:2408.10509#pg8>.
Ruth: It means we can move past just binary treatments and start looking at how outcomes vary across different treatment intensities with more rigor and precision #page two of that work reads: "there is growing interest in extending DiD to continuous treatments."
Warren: So, for the listener, it’s about having a new way to analyze policy or exposure effects that aren't just on or off, but are spread out across a continuum <ref:2408.10509#pg1>.
Iris: It’s about giving researchers more tools to look at these complex exposures with better identification and inference than what was previously available in this area <ref:2408.10509#pg8>.
More episodes
- Daily Summary for 2026-11-19
- 2608.21274-Recommendation Quality and the Concentration of Consumption: Experimental Evidence from Netflix
- 2408.02757-A nonparametric test for diurnal variation in spot correlation processes
- 2306.16393-High-Dimensional Canonical Correlation Analysis
- 2605.17299-Geometric Brownian motion with intermittent entries and exits
- 2607.04753-Fooling Yourself: how narratives shape beliefs
- 2408.14671-Inference on Treatment Effects with Repeatedly Mismeasured High-Dimensional Controls
- 2201.06898-Difference-in-Differences Estimators for Treatments Continuously Distributed at Every Period
- 2501.15307-Influence Functions: A Unified Differentiation-Based Framework
- The day in conversation for 2026-11-19